Additional information
| Weight | 0.94 oz |
|---|
Reduced L-glutathione (GSH) research compound supplied as 600mg lyophilized material for cellular redox studies. Batch B002 was tested and archived for transparency only; it will not be made available to researchers. Batch B003 is being acquired and will be independently tested before availability. For research use only - not for human consumption.
Batch B002 was tested by Janoshik and returned a measured content of 622.01 mg with 93.603% purity. The same batch also passed endotoxin screening at <1 EU/vial.
Glutathione is a comparatively sensitive compound and may show degradation or related-compound formation more readily than many lyophilized peptides. Even with that context, this result does not meet the standard we want for release.
Batch B002 will not be made available to researchers. We are acquiring Batch B003 now and will publish updated third-party testing once the replacement batch is finalized.
Batch B003 control roadmap: release will use tighter batch subdivision, packaging-variation notes, a release checklist, and a clear summary of what changed since B002.
| Weight | 0.94 oz |
|---|